Kopran Ltd is Rated Sell by MarketsMOJO

1 hour ago
share
Share Via
Kopran Ltd is rated 'Sell' by MarketsMojo, with this rating last updated on 23 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 December 2025, providing investors with the most up-to-date view of the company's performance and outlook.



Current Rating Overview


MarketsMOJO currently assigns Kopran Ltd a 'Sell' rating, reflecting a cautious stance on the stock given its recent performance and underlying fundamentals. This rating was revised on 23 December 2025, when the Mojo Score improved modestly from 26 to 31 points, moving the grade from 'Strong Sell' to 'Sell'. Despite this slight improvement, the overall assessment remains negative, signalling that investors should approach the stock with prudence.



Here’s How Kopran Ltd Looks Today


As of 27 December 2025, Kopran Ltd continues to face significant challenges across multiple dimensions of its business. The company operates within the Pharmaceuticals & Biotechnology sector and is classified as a microcap, which often entails higher volatility and risk. The current Mojo Score of 31.0 and the 'Sell' grade reflect a combination of factors including quality, valuation, financial trend, and technical outlook.



Quality Assessment


The quality grade for Kopran Ltd is assessed as average. This indicates that while the company maintains some operational capabilities, it has not demonstrated robust growth or resilience in recent years. The long-term growth trajectory remains weak, with operating profit declining at an annualised rate of -11.79% over the past five years. This sustained contraction in profitability undermines confidence in the company’s ability to generate consistent returns for shareholders.



Valuation Perspective


From a valuation standpoint, Kopran Ltd is currently considered attractive. This suggests that the stock price may be undervalued relative to its peers or intrinsic worth, potentially offering a margin of safety for investors. However, attractive valuation alone does not offset the risks posed by deteriorating fundamentals and negative financial trends. Investors should weigh this factor carefully against other metrics before making investment decisions.



Financial Trend Analysis


The financial trend for Kopran Ltd is very negative. The latest quarterly results, as of September 2025, reveal a sharp decline in net sales by 22.2%, accompanied by a net loss after tax (PAT) of ₹9.92 crores, representing a fall of 234.4%. The company has reported negative results for five consecutive quarters, signalling persistent operational difficulties. Return on capital employed (ROCE) is notably low at 5.38%, and the operating profit to interest coverage ratio stands at a concerning -2.53 times, indicating that earnings are insufficient to cover interest expenses. These metrics highlight the financial strain the company is under and the challenges it faces in returning to profitability.



Technical Outlook


Technically, Kopran Ltd is rated as mildly bearish. The stock has experienced significant volatility, with a one-day decline of 0.77% as of 27 December 2025. Over the past year, the stock has delivered a negative return of -30.97%, underperforming the broader BSE500 index across multiple time frames including one year, three months, and three years. Although there have been short-term rallies, such as a 14.69% gain over the past week and an 11.51% increase in the last month, these have not been sufficient to reverse the overall downward trend.




Register here to know the latest call on Kopran Ltd



  • - Fundamental Analysis

  • - Technical Signals

  • - Peer Comparison


Register Now →




Investor Implications of the 'Sell' Rating


The 'Sell' rating on Kopran Ltd suggests that the stock is expected to underperform relative to the broader market or sector peers in the near to medium term. For investors, this rating serves as a cautionary signal to consider reducing exposure or avoiding new positions until there is clear evidence of a turnaround. The combination of weak financial results, poor profitability metrics, and a bearish technical outlook indicates that the company faces significant headwinds.



Market Participation and Sentiment


Another noteworthy aspect is the minimal interest from domestic mutual funds, which hold only 0.01% of Kopran Ltd’s equity. Given that mutual funds typically conduct thorough on-the-ground research, their limited stake may reflect concerns about the company’s valuation or business prospects. This lack of institutional confidence further underscores the challenges Kopran Ltd faces in attracting investor support.



Comparative Performance


When benchmarked against the BSE500 index, Kopran Ltd’s stock has underperformed consistently over the last three years, one year, and three months. This persistent underperformance highlights the stock’s relative weakness and the difficulty in generating positive returns for shareholders. The negative returns of -30.97% over the past year are particularly significant, signalling that the company has struggled to regain investor confidence despite occasional short-term rallies.




Our latest weekly pick is out! This Large Cap from Steel/Sponge Iron/Pig Iron delivered with target price and complete analysis. See what makes this week's selection special!



  • - Latest weekly selection

  • - Target price delivered

  • - Large Cap special pick


See This Week's Special Pick →




Summary and Outlook


In summary, Kopran Ltd’s current 'Sell' rating by MarketsMOJO reflects a comprehensive evaluation of its operational quality, valuation, financial health, and technical indicators as of 27 December 2025. While the valuation appears attractive, the company’s ongoing financial difficulties, poor profitability, and weak stock performance weigh heavily against a positive outlook. Investors should carefully consider these factors and monitor future quarterly results and market developments before committing capital.



Given the persistent negative earnings and lack of institutional backing, the stock remains a high-risk proposition. Those holding the stock may want to reassess their positions, while prospective investors should await clearer signs of recovery before entering.






{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News